Chemoresistance of Plasmodium falciparum in the urban area of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Yaounde, Cameroon;Chimioresistance de P. falciparum en milieu urbain a Yaounde, Cameroun. Part 2: Evaluation de l'efficacite de l'amodiaquine et de l'association sulfadoxine-pyrimethamine pour le traitement de l'acces palustre simple a Plasmodium falciparum a Yaounde, Cameroun

Tropical Medicine and International Health

Volumn 5, Issue 9, 2000, Pages 620-627

  Ringwald, P ^a,b,f   Keundjian, A ^c   Same Ekobo, A ^d,e   Basco, L K ^a,b  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^b Institut de Recherche pour le Developpement Cameroon   (Cameroon)

^c SERVICE DE SANTÉ DES ARMÉES   (France)

^d Universite de Yaounde I Faculte de Medecine   (Cameroon)

^e Ministere de la Sante Publique   (Cameroon)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Amodiaquine; Chloroquine; Drug resistance; In vitro assay; In vivo test; Malaria; Sulfadoxine pyrimethamine

Indexed keywords

AMODIAQUINE; CHLOROQUINE; DEETHYLAMODIAQUINE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; DRUG DERIVATIVE; SULFADOXINE-PYRIMETHAMINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ASTHENIA; CAMEROON; DRUG BLOOD LEVEL; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; RASH; SCHOOL CHILD; VERTIGO; ANIMAL; BLOOD; CHILD; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; DRUG SENSITIVITY; HEALTH; MALARIA FALCIPARUM; MIDDLE AGED; PARASITOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMODIAQUINE; ANIMALS; ANTIMALARIALS; CAMEROON; CHILD; DRUG COMBINATIONS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME; URBAN HEALTH;

EID: 0033777150     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2000.00614.x     Document Type: Article

References (23)

1. Molecular epidemiology of malaria in Yaounde, Cameroon. IV. Evolution of pyrimethamine resistance between 1994 and 1998
2. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil
3. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites
4. Cutaneous disease and drug reacrions in HIV infection
5. Simultaneous measurement of sulfadoxine, N-4-acetylsulphadoxine and pyrimethamine in human plasma
6. Malaria-treatment policies: When and how should they be changed?
7. Acces palustres simples en zone de hater niveau de resistance a la chloroquine. 2. Evaluation de schemas therapeutiques de premiere intention
8. Acces palustres simples en zone de haut niveau de resistance a la chloroquine. 3. Emploi de traitements de deuxieme intention, par voie orale
9. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulfadoxine in Gambian children with uncomplicated malaria
10. Efficacy of sulfadoxine/pyrimethamine for Plasmodium falciparum in Malawian children under five years of age
11. Systematic review of amodiaquine treatment in uncomplicated malaria
12. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain
13. Risk factors for gametocyte carriage in uncomplicated falciparum malaria
14. Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography
15. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: Implications for malaria transmission control programme
16. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon
17. Surveillance in vitro et in vivo de la resistance de Plasmodium falciparum a la chloroquine entre 1994 et 1999 a Yaounde, Cameroun
18. Impact of chloroquine resistance on malaria mortality
19. A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya
20. Resistance to chloroquine and sulfadoxine-pyrimethamine in Muheza district, Tanzania
21. Preventing antimalarial drug resistance through combinations